KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ginkgo Bioworks Holdings (DNA) FCF Margin (2020 - 2025)

Historic FCF Margin for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to 81.38%.

  • Ginkgo Bioworks Holdings' FCF Margin rose 518000.0% to 81.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 103.64%, marking a year-over-year increase of 740400.0%. This contributed to the annual value of 168.31% for FY2024, which is 345600.0% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its FCF Margin stood at 81.38% for Q3 2025, which was up 518000.0% from 81.23% recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' FCF Margin's 5-year high stood at 13.75% during Q3 2021, with a 5-year trough of 252.92% in Q1 2024.
  • Over the past 5 years, Ginkgo Bioworks Holdings' median FCF Margin value was 128.05% (recorded in 2024), while the average stood at 119.27%.
  • In the last 5 years, Ginkgo Bioworks Holdings' FCF Margin soared by 1449500bps in 2022 and then plummeted by -1223900bps in 2023.
  • Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' FCF Margin stood at 114.92% in 2021, then fell by -15bps to 132.45% in 2022, then plummeted by -33bps to 176.31% in 2023, then rose by 27bps to 128.05% in 2024, then skyrocketed by 36bps to 81.38% in 2025.
  • Its FCF Margin was 81.38% in Q3 2025, compared to 81.23% in Q2 2025 and 122.4% in Q1 2025.